BLOOD GASES/PC02, PO2 ANALYSIS PRODUCTS— 510(k) K902267

Substantially Equivalent

Phoenix Diagnostics, Inc.

FDA 510(k) clearance K902267 for BLOOD GASES/PC02, PO2 ANALYSIS PRODUCTS, Substantially Equivalent on 1990-06-12. Applicant: Phoenix Diagnostics, Inc..

Clearance details

Applicant: Phoenix Diagnostics, Inc.
Product code: Code CHL
Advisory panel: Clinical Chemistry
Date received: 1990-05-21
Decision date: 1990-06-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code CHL

product code CHL

Death: 20
Malfunction: 999
Total: 1,019

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.